Cormorant Asset Management Healthcare News

This is selected healthcare news for Cormorant Asset Management, which is filed under Capital Firms. There are 266 news items for this page. Cormorant Asset Management is occasionally combined with Bigfoot Biomedical, Element Science and Freenome in news items. A press release filter page is also available for Cormorant Asset Management.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
11/23/2022 Scoop: Versant, NEA launch new biotech helmed by ex-CEO of protein degrader C4 Therapeutics – Endpoints News
... SEC this week. The round could balloon to $60 million. Phillips, who left protein degradation startup C4 in 2020 to be a managing director at Cormorant Asset Management, is running the show of the new venture as president, the SEC filing outlines. He also served as interim CEO of Cormorant ...
endpts.com
11/21/2022 FogPharma Announces $178 Million Series D Financing to Advance Pipeline of First-in-Class Helicon Polypeptide Therapeutics Targeting Major Cancer Drivers | Business Wire
... The financing round includes new investors ARCH Venture Partners, Milky Way Investments and Fidelity Management & Research Company and existing investors VenBio Partners, Deerfield Management, GV, Cormorant Asset Management, funds and accounts advised by T. Rowe Price Associates, Inc., Invus, Farallon Capital Management, HBM Healthcare Investments, Casdin Capital, and PagsGroup, also ...
Business Wire
11/21/2022 FogPharma Announces $178 Million Series D Financing to Advance Pipeline of First-in-Class Helicon Polypeptide Therapeutics Targeting Major Cancer Drivers
... The financing round includes new investors ARCH Venture Partners, Milky Way Investments and Fidelity Management & Research Company and existing investors VenBio Partners, Deerfield Management, GV, Cormorant Asset Management, funds and accounts advised by T. Rowe Price Associates, Inc., Invus, Farallon Capital Management, HBM Healthcare Investments, Casdin Capital, and PagsGroup, also ...
pharmaceuticaldaily.com
11/21/2022 FogPharma raises $178M to target cancer
... The financing round includes new investors ARCH Venture Partners, Milky Way Investments and Fidelity Management & Research Company and existing investors VenBio Partners, Deerfield Management, GV, Cormorant Asset Management, funds and accounts advised by T. Rowe Price Associates, Inc., Invus, Farallon Capital Management, HBM Healthcare Investments, Casdin Capital, and PagsGroup, also ...
labiotech.eu
11/4/2022 Rain Therapeutics Announces $50 Million Registered Offering
... Leading life science investors are participating in the offering, including Deerfield Management Company, Adage Capital Partners LP, BVF Partners L.P., Boxer Capital, Janus Henderson Investors, Cormorant Asset Management, and Samsara BioCapital. Guggenheim Securities, LLC is acting as sole book-running manager for the offering and H.C. Wainwright & Co. and JonesTrading ...
Globe Newswire
11/4/2022 Rain Therapeutics Announces $50 Million Registered Offering of Common Stock
... Leading life science investors are participating in the offering, including Deerfield Management Company, Adage Capital Partners LP, BVF Partners L.P., Boxer Capital, Janus Henderson Investors, Cormorant Asset Management, and Samsara BioCapital. Guggenheim Securities, LLC is acting as sole book-running manager for the offering and H.C. Wainwright & Co. and JonesTrading ...
Yahoo News
11/4/2022 Rain Therapeutics Announces $50 Million Registered Offering of Common Stock
... Leading life science investors are participating in the offering, including Deerfield Management Company, Adage Capital Partners LP, BVF Partners L.P., Boxer Capital, Janus Henderson Investors, Cormorant Asset Management, and Samsara BioCapital. Guggenheim Securities, LLC is acting as sole book-running manager for the offering and H.C. Wainwright & Co. and JonesTrading ...
biotechwinners.com
10/31/2022 Riccardo Sabatini, from Cremona on the roof of the scientific world
... revolutionary approach to tackling complex diseases such as cancer. These days they announced that they have closed a Series C round for $ 55 million (from Cormorant Asset Management, Novartis and a number of high-caliber investment funds). Now human experimentation begins. ‚AuA deep-tech startup has incredible barriers to overcome ...
breakinglatest.news
10/31/2022 Erasca Inc. (ERAS) Performance and Fundamentals Dashboard tells a completely different story
... the largest shareholder in ERAS with 14.33% of the stake, Fidelity Management & Research Co holds 17,499,928 shares worth 17,499,928. A second-largest stockholder of ERAS, Cormorant Asset Management LP, holds 10,505,554 shares, controlling over 8.60% of the firm's shares. PFM Health Sciences LP is the third largest shareholder in ...
setenews.com
10/26/2022 Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., to its Board of Directors | Business Wire
... developing transformative oral medicines for severe RNA-mediated diseases, today announced the appointment of Raymond J. Kelleher, M.D., Ph.D., to its Board of Directors representing Cormorant Asset Management. Dr. Kelleher is an accomplished neurologist and neuroscientist, company founder, and investor, who serves on several boards for leading biotechnology and pharmaceutical ...
Business Wire
10/26/2022 Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., to its Board of Directors
... developing transformative oral medicines for severe RNA-mediated diseases, today announced the appointment of Raymond J. Kelleher, M.D., Ph.D., to its Board of Directors representing Cormorant Asset Management. Dr. Kelleher is an accomplished neurologist and neuroscientist, company founder, and investor, who serves on several boards for leading biotechnology and pharmaceutical ...
acrofan.com
10/26/2022 Element Science Appoints Trish Howell as Chief Operating Officer | Business Wire
... of potentially experiencing a lethal heart rhythm. Based in San Francisco, our funders include Third Rock Ventures, Google Ventures, Deerfield Management, Qiming Venture Partners USA, Cormorant Asset Management, and Invus Opportunities. For more information please visit www.elementscience.com. Contacts Press Contact: Beth Kurth Conway Communications [email protected] ...
Business Wire
10/26/2022 Element Science Appoints Trish Howell as Chief Operating Officer
... of potentially experiencing a lethal heart rhythm. Based in San Francisco, our funders include Third Rock Ventures, Google Ventures, Deerfield Management, Qiming Venture Partners USA, Cormorant Asset Management, and Invus Opportunities. For more information please visit www.elementscience.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20221026005296/en/ Contacts Press ...
Yahoo News
10/26/2022 Element Science Appoints Trish Howell as Chief Operating Officer
... of potentially experiencing a lethal heart rhythm. Based in San Francisco, our funders include Third Rock Ventures, Google Ventures, Deerfield Management, Qiming Venture Partners USA, Cormorant Asset Management, and Invus Opportunities. For more information please visit www.elementscience.com. Contacts Press Contact: Beth Kurth Conway Communications ...
cardiacvascularnews.com
10/25/2022 JenaValve Appoints Duane Pinto, MD, MPH, as Chief Medical Officer
... Leeds, U.K., and Munich, Germany. JenaValve is backed by Bain Capital Life Sciences, Andera Partners (formerly Edmond de Rothschild Investment Partners), Valiance Life Sciences, Gimv, Cormorant Asset Management, Legend Capital, NeoMed Management, RMM, VI Partners, Pictet Alternative Advisors SA, Qatar Investment Authority (QIA), Innovatus Capital Partners, and Peijia Medical Limited ...
cardiacvascularnews.com
10/24/2022 JenaValve Appoints Duane Pinto, MD, MPH, as Chief Medical
... Leeds, U.K., and Munich, Germany. JenaValve is backed by Bain Capital Life Sciences, Andera Partners (formerly Edmond de Rothschild Investment Partners), Valiance Life Sciences, Gimv, Cormorant Asset Management, Legend Capital, NeoMed Management, RMM, VI Partners, Pictet Alternative Advisors SA, Qatar Investment Authority (QIA), Innovatus Capital Partners, and Peijia Medical Limited ...
Globe Newswire
10/24/2022 JenaValve Appoints Duane Pinto, MD, MPH, as Chief Medical Officer
... Leeds, U.K., and Munich, Germany. JenaValve is backed by Bain Capital Life Sciences, Andera Partners (formerly Edmond de Rothschild Investment Partners), Valiance Life Sciences, Gimv, Cormorant Asset Management, Legend Capital, NeoMed Management, RMM, VI Partners, Pictet Alternative Advisors SA, Qatar Investment Authority (QIA), Innovatus Capital Partners, and Peijia Medical Limited ...
Yahoo News
10/24/2022 JenaValve Appoints Duane Pinto, MD, MPH, as Chief Medical Officer
... Leeds, U.K., and Munich, Germany. JenaValve is backed by Bain Capital Life Sciences, Andera Partners (formerly Edmond de Rothschild Investment Partners), Valiance Life Sciences, Gimv, Cormorant Asset Management, Legend Capital, NeoMed Management, RMM, VI Partners, Pictet Alternative Advisors SA, Qatar Investment Authority (QIA), Innovatus Capital Partners, and Peijia Medical Limited ...
healthtechnologynet.com
10/22/2022 State's Life Science Industry Attracted $5B in 2021 | News | 425business.com
... million, an M&A deal with Hillrom Holdings. - Umoja Biopharma Inc., of Seattle, total funding of $210 million, later stage VC, with lead investors of Cormorant Asset Management; SoftBank Investment Advisers (UK) Ltd.; and SoftBank Vision Fund. - Nautilus Biotechnology, of Seattle, total funding of $200 million, later stage VC, with ...
425business.com
10/20/2022 Artificial Intelligence in Oncology Report 2022: Spending on AI to Surpass $110 Billion by 2024
... Group CancerCenter.ai Canon Medical Systems Capitol Health Casdin Capital Catalio Capital Management Charles River Ventures China Merchant Securities International Colorectal Cancer Alliance ConcertAI Connect Ventures Cormorant Asset Management Cosmo Pharmaceuticals Coutts CPP Investments Cornerstone Total Return Fund CureMatch CureMetrix D.E. Shaw Research D1 Capital Partners Dana Farber Cancer Institute Danhua ...
PR Newswire
10/19/2022 Orionis Biosciences Secures $55M Financing Round
Orionis Biosciences , a Waltham, MA- and Gent, Belgium-based life sciences company, raised $55M in funding. The round was led by Cormorant Asset Management, and Novartis. Robert Petit joined as Head of Early Clinical Development; Bihua Chen was appointed to the Board of Directors. The company intends to use the ...
finsmes.com
10/12/2022 Stock Market | FinancialContent Business Page
... Group CancerCenter.ai Canon Medical Systems Capitol Health Casdin Capital Catalio Capital Management Charles River Ventures China Merchant Securities International Colorectal Cancer Alliance ConcertAI Connect Ventures Cormorant Asset Management Cosmo Pharmaceuticals Coutts CPP Investments Cornerstone Total Return Fund CureMatch CureMetrix D.E. Shaw Research D1 Capital Partners Dana Farber Cancer Institute Danhua ...
financialcontent.com
10/12/2022 Artificial Intelligence in Oncology Market Report 2022: AI Based Cancer Screening Has Resulted in Reduced Mortality Rates of Some Prevalent Malignanci
... Group CancerCenter.ai Canon Medical Systems Capitol Health Casdin Capital Catalio Capital Management Charles River Ventures China Merchant Securities International Colorectal Cancer Alliance ConcertAI Connect Ventures Cormorant Asset Management Cosmo Pharmaceuticals Coutts CPP Investments Cornerstone Total Return Fund CureMatch CureMetrix D.E. Shaw Research D1 Capital Partners Dana Farber Cancer Institute Danhua ...
acrofan.com
10/7/2022 Artificial Intelligence in Oncology Market Report 2022: Lower Rates of Diagnostic & Treatment Errors Brought By AI Boosts Adoption
... Group CancerCenter.ai Canon Medical Systems Capitol Health Casdin Capital Catalio Capital Management Charles River Ventures China Merchant Securities International Colorectal Cancer Alliance ConcertAI Connect Ventures Cormorant Asset Management Cosmo Pharmaceuticals Coutts CPP Investments Cornerstone Total Return Fund CureMatch CureMetrix D.E. Shaw Research D1 Capital Partners Dana Farber Cancer Institute Danhua ...
Yahoo News
10/7/2022 Artificial Intelligence in Oncology Market Report 2022: Lower Rates of Diagnostic & Treatment Errors Brought By AI Boosts Adoption
... Group - CancerCenter.ai - Canon Medical Systems - Capitol Health - Casdin Capital - Catalio Capital Management - Charles River Ventures - China Merchant Securities International - Colorectal Cancer Alliance - ConcertAI - Connect Ventures - Cormorant Asset Management - Cosmo Pharmaceuticals - Coutts - CPP Investments - Cornerstone Total Return Fund - CureMatch - CureMetrix - D.E. Shaw Research - D1 Capital Partners - Dana Farber Cancer Institute - Danhua ...
Globe Newswire